CD93 and systemic sclerosis: Moreover, the plasma concentration of sCD93 has been proposed as a biomarker for conditions such as systemic sclerosis [101], allergic asthma [107], glucose metabolism regulation [108], and coronary artery disease [6] (the specific role of CD93 in these diseases will be discussed in detail later).